United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2016_register
executive
2016-08-26
article
Schedules of Controlled Substances: Placement of Thiafentanil Into Schedule II
Rules and Regulations
D09002ee190d728e4
D09002ee190d72e06
United States
Department of Justice
originator
org
United States Government Agency or Subagency
United States
Drug Enforcement Administration
originator
org
United States Government Agency or Subagency
The Drug Enforcement Administration is placing the substance thiafentanil (4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2- (thienyl)ethyl]piperidine), including its isomers, esters, ethers, salts and salts of isomers, esters and ethers as possible, into schedule II of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act, as revised by the Improving Regulatory Transparency for New Medical Therapies Act which was signed into law on November 25, 2015.
81 FR 58834
https://www.govinfo.gov/app/details/FR-2016-08-26/2016-20463
2016-20463
fr26au16-11
4410-09-P
Docket No. DEA-375
https://www.govinfo.gov/app/details/FR-2016-08-26/2016-20463
https://www.govinfo.gov/content/pkg/FR-2016-08-26/html/2016-20463.htm
https://www.govinfo.gov/content/pkg/FR-2016-08-26/pdf/2016-20463.pdf
Administrative Practice and Procedure
Drug Traffic Control
Security Measures
Reporting and Recordkeeping Requirements
7 p.
58834
58840
81 FR 58834
Code of Federal Regulations
Title 21 Part 1301
21 CFR Part 1301
Code of Federal Regulations
Title 21 Part 1305
21 CFR Part 1305
Code of Federal Regulations
Title 21 Part 1308
21 CFR Part 1308
Schedules of Controlled Substances: Placement of Thiafentanil Into Schedule II; Federal Register Vol. 81, Issue
RULE
2016-20463
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
2016-08-26
Docket No. DEA-375
4410-09-P
2016-20463
Interim final rule with request for comments.
The Drug Enforcement Administration is placing the substance thiafentanil (4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2- (thienyl)ethyl]piperidine), including its isomers, esters, ethers, salts and salts of isomers, esters and ethers as possible, into schedule II of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act, as revised by the Improving Regulatory Transparency for New Medical Therapies Act which was signed into law on November 25, 2015.
The effective date of this rule is August 26, 2016. Interested persons may file written comments on this rule in accordance with 21 U.S.C. 811(j)(3) and 21 CFR 1308.43(g). Electronic comments must be submitted, and written comments must be postmarked, on or before September 26, 2016. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.
Michael J. Lewis, Office of Diversion
Administrative Practice and Procedure
Drug Traffic Control
Security Measures
Reporting and Recordkeeping Requirements
Schedules of Controlled Substances:
Placement of Thiafentanil into Schedule II
,
http://www.regulations.gov
Regulations.gov
Federal Register
Vol. 81, no. 166
Office of the Federal Register, National Archives and Records Administration
2016-08-26
continuing
daily
deposited
born digital
323 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2016-08-26
P0b002ee190d716d1
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr26au16
https://www.govinfo.gov/app/details/FR-2016-08-26
https://www.govinfo.gov/content/pkg/FR-2016-08-26/pdf/FR-2016-08-26.pdf
https://www.govinfo.gov/content/pkg/FR-2016-08-26/xml/FR-2016-08-26.xml
fdlp
58807
59119
DGPO
2016-08-26
2016-08-26
FR-2016-08-26
machine generated
eng
FR
FR-2016-08-26
81
166